|
1
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Calin GA, Sevignani C, Dumitru CD, et al:
Human microRNA genes are frequently located at fragile sites and
genomic regions involved in cancers. Proc Natl Acad Sci USA.
101:2999–3004. 2004. View Article : Google Scholar
|
|
3
|
Li X, Zhang Y, Zhang Y, Ding J, Wu K and
Fan D: Survival prediction of gastric cancer by a seven-microRNA
signature. Gut. 59:579–585. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kong KL, Kwong DL, Chan TH, et al:
MicroRNA-375 inhibits tumour growth and metastasis in oesophageal
squamous cell carcinoma through repressing insulin-like growth
factor 1 receptor. Gut. 61:33–42. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hsu KW, Wang AM, Ping YH, et al:
Down-regulation of tumor suppressor MBP-1 by microRNA-363 in
gastric carcinogenesis. Carcinogenesis. Oct 4–2013.(Epub ahead of
print).
|
|
6
|
Peng Y, Dai Y, Hitchcock C, et al: Insulin
growth factor signaling is regulated by microRNA-486, an
underexpressed microRNA in lung cancer. Proc Natl Acad Sci USA.
110:15043–15048. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang N, Wang X, Huo Q, et al:
MicroRNA-30a suppresses breast tumor growth and metastasis by
targeting metadherin. Oncogene. Jul 15–2013.(Epub ahead of
print).
|
|
8
|
Volinia S, Galasso M, Sana ME, et al:
Breast cancer signatures for invasiveness and prognosis defined by
deep sequencing of microRNA. Proc Natl Acad Sci USA. 109:3024–3029.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li D, Liu X, Lin L, et al: MicroRNA-99a
inhibits hepatocellular carcinoma growth and correlates with
prognosis of patients with hepatocellular carcinoma. J Biol Chem.
286:36677–36685. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Osada H and Takahashi T: let-7 and
miR-17–92: small-sized major players in lung cancer development.
Cancer Sci. 102:9–17. 2011.
|
|
11
|
Aqeilan RI, Calin GA and Croce CM: miR-15a
and miR-16-1 in cancer: discovery, function and future
perspectives. Cell Death Differ. 17:215–220. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wiklund ED, Bramsen JB, Hulf T, et al:
Coordinated epigenetic repression of the miR-200 family and miR-205
in invasive bladder cancer. Int J Cancer. 128:1327–1334. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
14
|
Hohenberger P and Gretschel S: Gastric
cancer. Lancet. 362:305–315. 2003. View Article : Google Scholar
|
|
15
|
Wu Q, Jin H, Yang Z, et al: MiR-150
promotes gastric cancer proliferation by negatively regulating the
pro-apoptotic gene EGR2. Biochem Biophys Res Commun. 392:340–345.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu T, Tang H, Lang Y, Liu M and Li X:
MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by
targeting prohibitin. Cancer Lett. 273:233–242. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chan SH, Wu CW, Li AF, Chi CW and Lin WC:
miR-21 microRNA expression in human gastric carcinomas and its
clinical association. Anticancer Res. 28:907–911. 2008.PubMed/NCBI
|
|
18
|
Kim YK, Yu J, Han TS, et al: Functional
links between clustered microRNAs: suppression of cell-cycle
inhibitors by microRNA clusters in gastric cancer. Nucleic Acids
Res. 37:1672–1681. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gao C, Zhang Z, Liu W, Xiao S, Gu W and Lu
H: Reduced microRNA-218 expression is associated with high nuclear
factor kappa B activation in gastric cancer. Cancer. 116:41–49.
2010.PubMed/NCBI
|
|
20
|
Luo H, Zhang H, Zhang Z, et al:
Down-regulated miR-9 and miR-433 in human gastric carcinoma. J Exp
Clin Cancer Res. 28:822009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Takagi T, Iio A, Nakagawa Y, Naoe T,
Tanigawa N and Akao Y: Decreased expression of microRNA-143 and
-145 in human gastric cancers. Oncology. 77:12–21. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ding L, Xu Y, Zhang W, et al: MiR-375
frequently downregulated in gastric cancer inhibits cell
proliferation by targeting JAK2. Cell Res. 20:784–793. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pan J, Hu H, Zhou Z, et al:
Tumor-suppressive mir-663 gene induces mitotic catastrophe growth
arrest in human gastric cancer cells. Oncol Rep. 24:105–112.
2010.PubMed/NCBI
|
|
24
|
Zhang Z, Li Z, Gao C, et al: miR-21 plays
a pivotal role in gastric cancer pathogenesis and progression. Lab
Invest. 88:1358–1366. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tsukamoto Y, Nakada C, Noguchi T, et al:
MicroRNA-375 is downregulated in gastric carcinomas and regulates
cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res.
70:2339–2349. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Du Y, Xu Y, Ding L, et al: Down-regulation
of miR-141 in gastric cancer and its involvement in cell growth. J
Gastroenterol. 44:556–561. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jiang L, Huang Q, Chang J, Wang E and Qiu
X: MicroRNA HSA-miR-125a-5p induces apoptosis by activating p53 in
lung cancer cells. Exp Lung Res. 37:387–398. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nishida N, Mimori K, Fabbri M, et al:
MicroRNA-125a-5p is an independent prognostic factor in gastric
cancer and inhibits the proliferation of human gastric cancer cells
in combination with trastuzumab. Clin Cancer Res. 17:2725–2733.
2011. View Article : Google Scholar
|
|
29
|
Odar K, Boštjančič E, Gale N, Glavač D and
Zidar N: Differential expression of microRNAs miR-21, miR-31,
miR-203, miR-125a-5p and miR-125b and proteins PTEN and p63 in
verrucous carcinoma of the head and neck. Histopathology.
61:257–265. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim JK, Noh JH, Jung KH, et al: Sirtuin7
oncogenic potential in human hepatocellular carcinoma and its
regulation by the tumor suppressors MiR-125a-5p and MiR-125b.
Hepatology. 57:1055–1067. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fassan M, Pizzi M, Realdon S, et al: The
HER2-miR125a5p/miR125b loop in gastric and esophageal
carcinogenesis. Hum Pathol. 44:1804–1810. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Krek A, Grun D, Poy MN, et al:
Combinatorial microRNA target predictions. Nat Genet. 37:495–500.
2005. View
Article : Google Scholar
|
|
33
|
Lewis BP, Shih IH, Jones-Rhoades MW,
Bartel DP and Burge CB: Prediction of mammalian microRNA targets.
Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human MicroRNA targets. PLoS Biol.
2:e3632004. View Article : Google Scholar
|
|
35
|
Cooper CS, Nicholson AG, Foster C, et al:
Nuclear overexpression of the E2F3 transcription factor in human
lung cancer. Lung Cancer. 54:155–162. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Feber A, Clark J, Goodwin G, et al:
Amplification and overexpression of E2F3 in human bladder cancer.
Oncogene. 23:1627–1630. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Foster CS, Falconer A, Dodson AR, et al:
Transcription factor E2F3 overexpressed in prostate cancer
independently predicts clinical outcome. Oncogene. 23:5871–5879.
2004. View Article : Google Scholar
|
|
38
|
Fang Y, Gu X, Li Z, Xiang J and Chen Z:
miR-449b inhibits the proliferation of SW1116 colon cancer stem
cells through downregulation of CCND1 and E2F3 expression. Oncol
Rep. 30:399–406. 2013.PubMed/NCBI
|
|
39
|
Vimala K, Sundarraj S, Sujitha MV and
Kannan S: Curtailing overexpression of E2F3 in breast cancer using
siRNA (E2F3)-based gene silencing. Arch Med Res. 43:415–422. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
McClellan KA, Ruzhynsky VA, Douda DN, et
al: Unique requirement for Rb/E2F3 in neuronal migration: evidence
for cell cycle-independent functions. Mol Cell Biol. 27:4825–4843.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ziebold U, Reza T, Caron A and Lees JA:
E2F3 contributes both to the inappropriate proliferation and to the
apoptosis arising in Rb mutant embryos. Genes Dev. 15:386–391.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Oeggerli M, Tomovska S, Schraml P, et al:
E2F3 amplification and overexpression is associated with invasive
tumor growth and rapid tumor cell proliferation in urinary bladder
cancer. Oncogene. 23:5616–5623. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ørom UA, Kauppinen S and Lund AH:
LNA-modified oligonucleotides mediate specific inhibition of
microRNA function. Gene. 372:137–141. 2006.PubMed/NCBI
|
|
44
|
Surdziel E, Eder M and Scherr M:
Lentivirus-mediated antagomir expression. Methods Mol Biol.
667:237–248. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Velu CS and Grimes HL: Utilizing antagomiR
(antisense microRNA) to knock down microRNA in murine bone marrow
cells. Methods Mol Biol. 928:185–195. 2012.PubMed/NCBI
|
